Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331630
Status:
COMPLETED
Last Update Posted:
2020-03-06
First Post:
2006-05-30
Brief Title:
Abraxane and Lapatinib in Treating Patients With Stage I Stage II or Stage III Breast Cancer
Sponsor:
Northwestern University
Organization:
Northwestern University
Organization Data
Organization:
Northwestern University
Class:
OTHER
Study ID:
NU 05B2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Northwestern University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |
| Celgene Corporation | INDUSTRY |